Screening, diagnostic and therapeutic methods relating to RIZ

Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or... – Involving transferase

Reexamination Certificate

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C435S193000, C530S327000

Reexamination Certificate

active

06989245

ABSTRACT:
The invention provides a method of screening for a compound that modulates RIZ histone methyltransferase (HMT) activity, by contacting a RIZ or RIZ fragment having HMT activity with one or more candidate compounds, and determining histone methyltransferase activity of the contacted RIZ or RIZ fragment. Also provided is a method of screening for a compound that modulates progesterone receptor (PR) activity, by providing a RIZ1 modulatory compound, and determining the ability of the RIZ1 modulatory compound to modulate PR activity. Further provided is a method of identifying an individual with an estrogen receptor positive (ER+) tumor having a reduced likelihood of responding to endocrine therapy. The method involves determining the RIZ1 status of the tumor, wherein an abnormal RIZ1 status identifies the individual as an individual with a reduced likelihood of responding to endocrine therapy.

REFERENCES:
patent: 5811304 (1998-09-01), Huang
patent: 6069231 (2000-05-01), Huang
patent: 6323335 (2001-11-01), Huang
patent: 6555329 (2003-04-01), Jenuwein et al.
patent: 6586579 (2003-07-01), Huang
patent: 2002/0039776 (2002-04-01), Jenuwein et al.
patent: 2002/0115215 (2002-08-01), Wolffe et al.
Buyse et al., “The retinoblastoma protein binds to RIZ, a zinc-finger protein that shares an epitope with the adenovirus E1A protein”,Proc. Natl. Acad. Sci.92:4667-4471 (1995).
Steele-Perkins et al., “Tumor formation and invactivation of RIZ1, and RB-binding member of a nuclear protein-methyltransferase superfamily”,Genes&Development15:2250-2262 (2001).
Abbondanza et al., “The retinoblastoma-interacting zinc-finger protein RIZ is a downstream effector of estrogen action,”Proc. Natl. Acad. Sci. USA97(7) :3130-3135 (2000).
Agadir et al., “Resistance of HBL100 human breast epithelial cells to vitamin D action,”Carcinogenesis20:577-582 (1999).
Allegra, “Methtrexate and 5-Fluorouracil following Tamoxifen and Premarin in advanced breast cancer,”Semin. Oncol.10:23-28 (1983).
Anzick et al., “AIB1, a steroid receptor coactivator amplified in breast and ovarian cancer,”Science277:965-968 (1997).
Bannister et al., “Selective recognition of methylated lysine 9 on histone H3 by the HP1 chromo domain,”Nature410:120-124 (2001).
Bhattacharjee et al., “Histone H1 phosphorylation by Cdk2 selectively modulates mouse mammary tumor virus transcription through chromatin remodeling,”Mol. Cell. Biol.21:5417-5425 (2001).
Buyse et al., “The retinoblastoma protein binds to RIZ, a zinc-finger protein that shares an epitope with the adenovirus E1A protein,”Proc. Natl. Acad. Sci. USA92:4467-4471 (1995).
Chadwick et al., “Candidate tumor suppressor RIZ is frequently involved in colorectal carcinogenesis,”Proc. Natl. Acad. Sci. USA97(6) : 2662-2667 (2000).
Dou and Gorovsky, “Phosphorylation of linker histone H1 regulates gene expression in vivo by creating a charge patch,”Mol. Cell.6:225-231 (2000).
Du et al., “Hypermethylation in human cancers of theRIZ1tumor suppressor gene, a member of a histone/protein methyltransferase superfamily,”Cancer Research61:8094-8099 (2001).
Elledge et al., “Estrogen receptor (ER) and progesterone receptor (PgR), by ligand-binding assay compared to tamoxifen in metastatic breast cancer: A Southwest oncology group study,”Int. J. Cancer89:111-117 (2000).
Evans et al., “The interactive web-based histology atlas system,”Oncogene19:989-991 (2000).
Gazzerro et al., “Differentiation of myeloid cell lines correlates with a selective expression of RIZ protein,”Mol. Med.7:552-560 (2001).
Gossler et al., “Transgenesis by means of blastocyst-derived embryonic stem cell lines, ”Proc. Natl. Acad. Sci. USA83:9065-9069 (1986).
Goulding et al., “A new immunohistochemical antibody for the assessment of estrogen receptor status on routine formalin-fixed tissue samples,”Human Pathology26(3):291-294 (1995).
Harvey et al., “Estrogen receptor status by immunohitchemistry is superior to the ligand-binding assay for predicting response to adjuvant endocrine therapy in breast cancer,”J. Clinical Oncology17(5) : 1474-1481 (1999).
He et al., “RIZ1, but not the alternative RIZ2 product of the same gene, is underexpressed in breast cancer, and forced RIZ1 expression causes G2-M cell cycle arrest and/or apoptosis,”Cancer Research58:4238-4244 (1998).
Hennighausen and Robinson, “Think globally, act locally: The making of a mouse mammary gland,”Genes&Development12:449-455 (1998).
Huang et al., “The PR domain of the Rb-binding zinc finger protein RIZ1 is a protein binding interface and is related to the SET domain functioning in chromatin-mediated gene expression,”J. Biol. Chem.273:15933-15939 (1988).
Jiang et al., “Adenovirus ExpressingRIZ1in tumor suppressor gene therapy of microsatellite-unstable colorectal cancers,”Cancer Research61:1796-1798 (2001).
Jiang et al., “Decreased RIZ1 expression but not RIZ2 in hepatoma and suppression of hepatoma tumorigenicity by RIZ1”Intl. J. Cancer83:541-546 (1999).
Jiang and Huang, “Theyin-yangof PR-domain family genes in tumorigenesis,”Histol. Histopathol.15:109-117 (2000).
Jordan, “Historical perspective on hormonal therapy of advanced breast cancer,”Clinical Therapeutics24: A3-A16 (Supplement A) (2002).
Kurebayashi et al., “Expression levels of Estrogen Receptor-α, estrogen Receptor-β, coactivators, and corepressors in breast cancer,”Clin. Cancer Res.6:512-518 (2000).
Lachner et al., “Methylation of histone H3 lysine 9 creates a binding site for HP1 proteins,”Nature410:116-120 (2001).
Leake, “Detection of the oestrogen receptor (ER) : immunohistochemical versus cytosol measurements,”European J. of Cancer36:S13-S23 (2000).
Lee et al, “A retinoic acid response element that overlaps an estrogen response element mediates multihormonal sensitivity in transcriptional activation of the lactoferrin gene,”Mol. Cell. Biol.15:4194-4207 (1995).
Liu et al., “The retinblastoma interacting zinc finger gene RIZ produces a PR domain-lacking product through an internal promoter,”J. Biol. Chem.272(5) : 2984-2991 (1997).
Lubahn et al., “Alteration of reproductive function but not prenatal sexual development after insertional disruption of the mouse estrogen receptor gene,”Proc.Natl. Acad Sci. USA90:1162-11166 (1993).
Lydon et al., “Mice lacking progesterone receptor exhibit pleiotropic reproductive abnormalities,”Genes&Development9:2266-2278 (1995).
Mansour et al., “Disruption of the proto-oncogeneint-2 in mouse embryo-derived stem cells: a general strategy for targeting mutations to non-selectable genes,”Nature336:348-352 (1988).
McKay and Cidlowski, “Cross-talk between nuclear factor-□B and the steroid hormone receptors: Mechanism of mutual antagonism,”Endocrinol.12:45-56 (1998).
Medici et al., “Identification of a DNA binding protein cooperating with estrogen receptor as RIZ (retinoblastoma interacting zinc finger protein), ”Biochem. and Biophys. Research Commun.264:983-989 (199).
Murphy et al., “Altered expression of estrogen receptor coregulators during human breast tumorigenesis,”Cancer Res.60:6266-62712 (2000).
Nakayama et al., “Role of histone H3 lysine 9 methylation in epignetic control of heterochromatin assembly,”Science292:110-113 (2001).
Nishioka et al., “Set9, a novel histone H3 methyltransferase that facilitates transcription by precluding histone tail modifications required for heterochromatin formation,”Genes&Dev.16:479-489 (2002).
Noma et al., “Transitions in distinct histone H3 methylation patterns at the heterochromatin domain boundaries,”Science293:1150-1155 (2001).
Ohe et al., “Human Spleen Histone H1. Iso

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Screening, diagnostic and therapeutic methods relating to RIZ does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Screening, diagnostic and therapeutic methods relating to RIZ, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Screening, diagnostic and therapeutic methods relating to RIZ will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-3578370

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.